Ribosomal and ribonucleic acid (RNA)-rich preparations derived from Salmonella typhimurium were examined for their ability to enhance the primary in vitro antibody response Bacteria and extracts. S. typhimurium strain W118-2 was used (1, 7). The organisms were cultured in brain heart infusion broth exactly as previously described (7). The intraperitoneal 50% lethal dose was 104 organisms for responder mice and less than 10 cells for the C3H/HeJ mice. Acetone-killed bacteria were used as the vaccine and were prepared as described previously by Angerman and Eisenstein (1). 
Ribosomal and ribonucleic acid (RNA)-rich preparations derived from Salmonella typhimurium were examined for their ability to enhance the primary in vitro antibody response of normal mouse spleen cell cultures to sheep erythrocytes. Both of these fractions were consistently more active in elevating the antibody response of normal mouse splenocytes from lipopolysaccharide (LPS) responder mice than was LPS. Furthermore, injection of mice with either the ribosomal or RNA-rich fraction induced antibody response helper factor activity in 2-h post-treatment serum similar to that induced by LPS. Endotoxin lowresponder C3H/HeJ mice were stimulated to release helper factors by ribosomes and the RNA extracts but not by LPS. Treatment of the ribosomes and RNA fractions with ribonuclease destroyed their ability to stimulate the production of the helper factor in serum of treated mice. Therefore, it appears likely that ribosomes and RNA-rich fractions stimulated an intermediate helper factor due to the presence of RNA and not LPS.
Previous studies have shown that ribosomerich vaccines derived from Salmonella typhimurium enhance specific resistance to challenge infection and are at least as effective as lipopolysaccharide (LPS) extracts derived from the same microorganism (1, 5) . Results of those studies also showed that ribosomal preparations from the bacteria had adjuvant activity (6) . Furthermore, preliminary studies showed that ribonucleic acid (RNA)-rich extracts derived from the salmonella were as potent mitogens as lipopolysaccharide (LPS) for murine splenocytes in vitro. These extracts also induced heightened in vitro immune responses of mouse spleen cells to sheep erythrocytes (SRBC). In this study, ribosomal, RNA-rich, and LPS preparations from S. typhimurium were examined for their ability to enhance the primary antibody responses of normal mouse splenocytes immunized in vitro with SRBC. The enhanced antibody responses noted were related to induction of antibody response helper factor(s). Serum from treated mice or culture supernatant fluids from spleen cells treated with any of the three preparations stimulated heightened immune responses by normal splenocyte cultures, indicating that the effects were due to release of intermediary immunoenhancing substances.
MATERIALS AND METHODS
Animals. BALB/c mice, 6 (1, 7) . The organisms were cultured in brain heart infusion broth exactly as previously described (7) . The intraperitoneal 50% lethal dose was 104 organisms for responder mice and less than 10 cells for the C3H/HeJ mice. Acetone-killed bacteria were used as the vaccine and were prepared as described previously by Angerman and Eisenstein (1 to LPS derived from gram-negative bacteria (11) . Thus, in an additional series of experiments, serum was obtained from either low-responder C3H/HeJ mice or high-responder C3H/ FeJ mice injected with either LPS, ribosomes, or RNA extracts from the salmonella and tested for effects on the antibody response of spleen cells from normal BALB/c mice. Serum from LPS-treated C3H/HeJ mice had only a slight effect on the antibody response of the splenocyte cultures as compared with the enhanced response of the spleen cells treated with serum from the C3H/FeJ high-responder mice (Table  3 ). In contrast, sera obtained from all mice injected with ribosomes or RNA extracts resulted in essentially the same level of increase in antibody formation by the target spleen cell cultures. The results of these experiments suggested that the immunoenhancing activity of the ribosomes and RNA-rich material was not due to endotoxin, since LPS per se did not induce an immunoenhancing activity in the sera of the C3H/HeJ mice. To examine this point in more detail, ribosome-and RNA-rich fractions were first incubated with 20 U of ribonuclease (RNase) per ml for 2 h at 370C before injection into the mice (Table 4) . Post-treatment sera from both groups of mice lacked the ability to stimulate an enhanced immune response, indicating that the enzyme had abolished the ability of these materials to stimulate a factor in the serum with immunoenhancing activity on addi- (1, 7) . Other studies in this laboratory have suggested that LPS "contamination" of the ribosome-rich fraction may be involved in the immunostimulatory activity (5) . In this regard it should be noted that earlier studies in this laboratory indicated that LPS derivatives obtained VOL. 32, 1981 on January 11, 2018 by guest http://iai.asm.org/ from salmonella, although immunogenic and capable of inducing some degree of protective immunity, were often not as effective as ribosomerich extracts per se (1, 7) . Furthermore, RNArich extracts derived from salmonella also were found to protect mice against challenge with specific bacteria. The ribosomal and RNA-rich fractions were shown to have nonspecific mitogenic and adjuvant activity for normal mouse splenocyte cultures (6) . In the present study, we observed that these materials, when injected into mice, resulted in development of post-treatment serum which had immunostimulating activity similar to that observed when LPS derived from salmonella or other bacteria was injected into mice.
It is now widely accepted that LPS, when given to mice, may induce development of soluble immunomodulatory factors (3). Furthermore, addition of LPS to macrophage cultures in vitro has been shown to induce lymphocyteactivating factor as well as other monokines. Thus, it seemed of value to determine whether ribosomal and RNA-rich extracts derived from salmonella could alter the immune response of normal splenocytes in a manner similar to bacterial LPS. Such immunoenhancement could be due either to contamination with LPS or to other cell wall-associated antigenic moieties. It is evident from the results of this study that the ribosomes and RNA-rich extracts, when injected into mice in a manner similar to that used in previous experiments with LPS, induced immunoenhancing post-treatment serum. The serum from mice injected with the RNA-rich materials was as effective as the LPS-induced post-treatment serum in enhancing in vitro antibody responses of normal mouse splenocytes to SRBC.
It is noteworthy that whereas C3H/HeJ mice did not produce immunostimulatory factors in response to LPS, these mice did respond to injection of ribosomal and RNA extracts by producing serum helper factor activity. It seemed evident that the RNA moieties present in these salmonella-derived fractions were the inducers of the immunoenhancing material, since treatment with RNase inactivated biological activity. For example, injection of RNase-treated ribosomes or RNA fractions into mice failed to elicit a serum factor(s) which had immunostimulatory activity, whereas RNase-treated LPS was still active. Therefore, it appears unlikely that the ribosomal and RNA-rich extracts contain contaminating LPS responsible for the immunomodulating effects noted. Since nonbacterial preparations have been found to be an adjuvant in some model systems, both in vivo and in vitro, it seems likely that activity of the ribosome fraction was also due to RNA. These observations support previous conclusions from this laboratory that ribosomal "vaccine" may exert a positive protective effect by serving as a complex of an immunogen and a nonspecific immunological adjuvant due to the immunostimulating properties of RNA-rich moieties.
It is of interest that similar serum immunoenhancing activity appeared in mice treated not only with the LPS but also with the ribosomes and RNA extracts. Therefore, it seems possible that a common pathway in induction of immune stimulation may occur in terms of these three materials, i.e., LPS, ribosomes, and RNA, even though the actual stimulating agent is quite different. Thus induction of intermediary factors, perhaps lymphokines or monokines, may be responsible for the adjuvant activity of these molecules and the adjuvanticity of the salmonella per se. Additional studies are in progress to determine whether specific immunity, as determined by resistance to challenge infection with salmonella, is similarly mediated by intermediary factors developing in the serum of the animals injected with either LPS ribosomes or RNA extracts. In vitro studies are also in progress in which similar immunoenhancing factors from spleen cell cultures exposed to ribosomes or RNA are being studied in regard to whether immunoenhancing factors can be produced.
